Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
- (-) Isotope Science and Enrichment Directorate (6)
Researcher
- William Carter
- Alex Roschli
- Andrzej Nycz
- Brian Post
- Chris Masuo
- Luke Meyer
- Mike Zach
- Adam Stevens
- Alex Walters
- Amy Elliott
- Andrew F May
- Ben Garrison
- Brad Johnson
- Bruce Moyer
- Cameron Adkins
- Charlie Cook
- Christopher Hershey
- Craig Blue
- Daniel Rasmussen
- Debjani Pal
- Erin Webb
- Evin Carter
- Hsin Wang
- Isha Bhandari
- James Klett
- Jeffrey Einkauf
- Jennifer M Pyles
- Jeremy Malmstead
- John Lindahl
- Joshua Vaughan
- Justin Griswold
- Kitty K Mccracken
- Kuntal De
- Laetitia H Delmau
- Liam White
- Luke Sadergaski
- Michael Borish
- Nedim Cinbiz
- Oluwafemi Oyedeji
- Padhraic L Mulligan
- Peter Wang
- Rangasayee Kannan
- Roger G Miller
- Ryan Dehoff
- Sandra Davern
- Sarah Graham
- Soydan Ozcan
- Sudarsanam Babu
- Tony Beard
- Tyler Smith
- William Peter
- Xianhui Zhao
- Yukinori Yamamoto
11 - 13 of 13 Results

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence